Four hundred and forty-nine short children, who were all over 2-5 standard deviations below the mean height for age, were identified by screening the heights of 48 221 6-to 9-year-old children in three Scottish cities. Most were screened for growth hormone deficiency (GHD). The prevalence of severe GHD in this sample may have been as high as 1 in 4018, much higher than reported. The findings suggest that present referral patterns may
to cross the boundary to category 1 or more pneumoconiosis. This is in fact what happened and it is shown by the greater proportion who developed pneumoconiosis (table II) and the separation between the lines in fig 1. Nevertheless, the similarity of the dose-response curves shown in fig 2 shows that the presence or absence of sputum had no effect on the attack rate of pneumoconiosis.
The implications of a possible interaction between bronchitis and pneumoconiosis were discussed in detail by Davies.1 For many years there has been controversy over the question of disability and abnormalities of respiratory function in men with pneumoconiosis. Most workers have found little difference in the results of simple function tests (FEV,, FVC) between miners with normal radiographs and those with simple pneumoconiosis." 22 Higgins et al '5 even reported that miners without pneumoconiosis had, on average, more impairment of respiratory function than those with early simple pneumoconiosis. Davies' considered that simple pneumoconiosis could cause disability and he suggested that the reason why epidemiologists were unable to show the true extent of this might be because bronchitis offered some protection against pneumoconiosis. Since bronchitis is one of the diseases associated with airways obstruction, there was little difference between the results of pulmonary function tests among groups of miners with or without pneumoconiosis. One group was disabled by bronchitis and the other by pneumoconiosis.
Our results do not support this hypothesis. They are compatible with a simple model in which dust exposure in the mining industry may cause pneumoconiosis, bronchitis, or both. There is no suggestion that mucus hypersecretion offers any protection against simple pneumoconiosis of coalworkers. The possibility that airflow obstruction, irrespective of mucus hypersecretion, could have a protective action cannot be excluded. An analysis of this specific problem will be made as soon as adequate data have been accumulated in the epidemiological research programme. It is unlikely that airways obstruction will turn out to have a different effect from hypersecretion of mucus since those men in the present survey with the symptoms of chronic bronchitis probably included many who also had impaired ventilatory capacity.
Introduction
The primary objective of the Scottish Survey of Short Stature has been to discover the prevalence of growth hormone deficiency (GHD). Information about the prevalence of this condition is important, as it indicates the likely therapeutic requirements for growth hormone (GH) were all those suffering from this condition being diagnosed.
In this study we defined severe GHD by the following criteria: (a) height over 2-5 standard deviations below mean height for age, (b) height velocity less than 25th centile for chronological age (over 1 year wherever possible), (c) maximum GH concentration of 9 mU/l or less in two or more diagnostic tests. By using artificial stimuli in a radioimmunoassay procedure it is nevertheless possible to miss occasional patients with biological GHD who will respond to treatment with GH despite apparently normal GH levels.' 2 Conversely, some children with low GH levels under experimental testing are capable of normal growth3 or, alternatively, fail to respond to administered human GH even in the absence of human GH antibodies. Treatment is discontinued in the absence of accelerated growth.
Survey method
The heights of 48 221 children (24 670 boys) aged 6 to 9 years who were attending all local authority primary and special schools and most fee-paying schools in Edinburgh, Aberdeen, and Glasgow were screened. Four hundred and forty-nine children with heights 2-5 standard deviations or more below the mean height for age6 were identified. The children were all in their second, third, or fourth years of school. They were measured in their classrooms using a Harpenden portable anthrompometer, and the smallest children were then remeasured by one of us (GVV), using the method described by Tanner et al,6 with a wall-mounted Harpenden stadiometer carried in a purpose-built mobile clinic. Eighty-eight per cent of 630 absentees thought by their class teachers to be small were measured on a later visit. There may have been up to nine short children among the small absentees who were not measured.
Permission was sought to undertake a screening test for GHD from the parents of all short children, except for 76 who had an organic basis for their short stature. Four of these had previously been diagnosed as suffering from GHD. Of the 373 children seven had previously been investigated and found not to have GHD. Of the remaining 366, 10 emigrated from the survey area before investigation, but two were measured subsequently and are known to have a normal height velocity. The parents of 76 children refused permission. Sixty-six of this group were remeasured, and only 29 had a height velocity less than the 25th centile for chronological age. Further information from the parents of these children suggested a possible genetic or organic basis-for example, low birth weight-in 16. Thirteen could not offer any adequate explanation. The 280 children outstanding were all screened for GHD. We were thus reasonably confident that an accurate assessment of the GH status could be made in all except 31 (6 9%).
Initial screening for GHD was by an insulin hypoglycaemia test in one child,7 an extended glucose tolerance test in four,8 and exercise in 275 children.9 Two hundred and twenty-seven children had blood sampled 30 minutes from the start of a 10-to 20-minute period of cycling against moderate resistance on an exercise cycle as recommended by others,9 10 and 48 had blood collected 30 minutes from the end of a similar period of exercise. Nine children who had low GH levels after exercise also had an extended glucose tolerance test. Most of those who had a height velocity less than the 25th centile for chronological age (measured over 12 months),6 GH levels under 10 mU/l, and no alternative explanation for their short stature, then had an insulin hypoglycaemia test. The only exceptions were children whose parents refused consent.
GH determinations were carried out by an automated specific radioimmunoassay using a second antibody separation stage 18) was less than that of the nine children found during the study ( -3 22), but the difference just failed to reach significance (t = 2-05; DF = 11; 005 <P <0 1). When the three children who may have been short for genetic reasons were excluded the mean height SD score ( --3 4) of the remaining children was not significantly different from that of those already diagnosed (t= 161; DF=8; 0-1 <P<02). Twelve-month height velocities were unavailable on four children, but in each case the interval height velocity was not inconsistent with a diagnosis of severe GHD. None of the children was severely disadvantaged, although 22% of the children studied fell into this category.
Although the diagnosis of GHD is essentially auxanological,4 the distinction between severe and partial GHD is essentially biochemical, although the more severely affected children will in general have a more extreme degree of growth retardation.' Centres disagree, however, about the maximum GH levels that are consistent with a diagnosis of severe deficiency, and levels of 6 to 10 mU/l have been suggested by different workers.' "1 In taken into account when calculating the prevalence of severe GHD, which in this population affected 14-5 to 27-0 individuals per 100 000 total population. When the three children whose short stature may have been genetic were omitted the prevalence was 14 5 to 20 7 per 100 000 (950, confidence limits 9-93-38-07 per 100 000).
We also found 96 children with GH levels of 10 to 20 mU/1 on screening. When necessary an insulin hypoglycaemia test was performed to determine those with partial GHD, but the diagnostic status of 25 children is still not clear and will be the basis of a later report.
Discussion
Only four (310I) of the 13 children with severe GHD had had their condition diagnosed before the study. Three of those found may have had a simple genetic basis for their short stature and merely responded inadequately to both insulin hypoglycaemia and exercise.16 Idiopathic GHD has, however, been described in more than one member of a family,"7 18 and in a recent review of 208 cases Rona and Tanner19 found that 4-500 of the brothers, 200 of the fathers, and 1-500 of the sisters and mothers of affected children also had GHD. Several of the parents in this study were extremely short ( The parents of five of the six newly diagnosed children in whom genetic factors could be excluded had consulted their general practitioners, but none of the children had been referred for further investigations. The parents of only one child had not been concerned about their child's short stature. None of the children with previously diagnosed GHD were girls, although five of the nine children found with GHD during the study were girls. The sex ratio found (1-0-1-6) was lower than the overall average of 2-9 reported recently.19 Although the numbers are too small to permit any definite statistical conclusion, the findings raise the possibility that GHD may be diagnosed relatively less often in affected girls.
None of the children were severely disadvantaged on the basis of our criteria. Although these may miss the more subtle degrees of deprivation, this was thought unlikely to be a significant problem in any child at the time of the survey, and thus none could be regarded as examples of psychosocial short stature with concomitant GHD.
Regrettably we have not had the time to extend the study to any of the more sparsely populated rural areas. The prevalence in the three cities does, however, seem to be similar despite considerable environmental differences between them. Clearly severe GHD is more common in this population than in the Newcastle area, where an incidence of 1 case in 30 000 has been reported. 20 Even at the lowest extreme of the confidence limits, GHD was almost twice as common, and may be as much as 11 times more common than this. If anything this figure is more likely to be an underestimate, since the parents of 10 children with low GH levels on exercise refused to allow them to have an insulin tolerance test to confirm the diagnosis. Based on an estimated incidence of one in 6000 births we would expect 125 cases to be found each year in Great Britain. At present about 90 new patients with GHD, with a mean age of 10- Summary A sensitive specific radioimmunoassay was developed to measure antibodies against BCG antigen 60, a prominent antigenic component of BCG bacilli which cross-reacts with similar components in many mycobacterial species including Mycobacterium leprae and M tuberculosis. A lepromatous serum pool had anti-BCG-60 activity with a titre of 105 and the tuberculoid pool a titre of 104. Testing of individual sera showed striking variations within groups of patients with lepromatous and tuberculoid leprosy. In five of the 20 tuberculoid leprosy sera the anti-BCG-60 activity was above the median for the lepromatous group. The current view that antibody formation against mycobacterial antigens is very low in tuberculoid leprosy thus no longer appears to be tenable. Sera from eight patients with active pulmonary tuberculosis also showed a striking variation in anti-BCG-60 content, and the median value of this group was even higher than in those with lepromatous leprosy.
Introduction
Leprosy is an example of a "spectral" disease-that is, one that shows considerable variations in clinical course. view is that polar lepromatous leprosy is characterised by lack of cell-mediated immunity towards Mycobacterium leprae, apparent uninhibited growth of the bacilli, and a high serum content of antibodies against various mycobacterial antigens. In the highly resistant form, tuberculoid leprosy, the reverse is the case: cellular immunity and hypersensitivity are well developed whereas antibodies to mycobacterial antigens occur infrequently and in low concentration. Crossed immunoelectrophoresis (CIE) has shown that several mycobacterial species contain more than 40 different antigenic components.6-9 To gain more insight into the immunology of leprosy and other mycobacterial diseases there is a great need for additional information on the immune response of the host against individual antigenic components of the mycobacteria.
Antigen 60 is a prominent antigenic component of BCG bacilli which cross-reacts with similar components in many mycobacterial species, including M leprae and M tuberculosis. We have produced monospecific antibodies against this antigen and have developed a specific radioimmunoassay (RIA) for measuring anti-BCG-60 antibodies in rabbit sera.'0 We report here our studies of anti-BCG-60 antibodies in sera from patients with lepromatous and tuberculoid leprosy and from several groups of controls, including patients with active pulmonary tuberculosis. The results obtained represent a challenge to the simplistic immunological model of leprosy outlined above.
Patients and methods
Purification and labelling of BCG antigen 60 by electrolytic iodination has been described in detail elsewhere.10 The preparation was tested as shown in fig 1. A mixture of 5 
